Janet Wolter

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh, Charles L. Vogel, Debu Tripathy et al. · Journal of Clinical Oncology · 1999 · 2.8K citations

Medicine, Oncology, Pharmacology +17

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Aman U. Buzdar, W. Jonat, Anthony Howell et al. · PubMed · 1998 · 418 citations

Medicine, Oncology, Pharmacology +15

Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen

Bernard Fisher, Carol Redmond, Ann Brown et al. · New England Journal of Medicine · 1981 · 290 citations

Medicine, Oncology, Pharmacology +17

A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma

Aman U. Buzdar, Stephen E. Jones, Charles L. Vogel et al. · Cancer · 1997 · 208 citations

Medicine, Oncology, Pharmacology +17